-
1
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958-965, 2001.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
-
2
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347: 975-982, 2002.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
3
-
-
1542378867
-
PEGASYS International Study Group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
-
Hadziyannis SJ, Sette H Jr, Morgan TR, et al. PEGASYS International Study Group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346-355, 2004.
-
(2004)
Ann Intern Med
, vol.140
, pp. 346-355
-
-
Hadziyannis, S.J.1
Sette Jr, H.2
Morgan, T.R.3
-
4
-
-
0030248901
-
Side effects of high-dose interferon therapy for chronic hepatitis C
-
Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25: 283-291, 1996.
-
(1996)
J Hepatol
, vol.25
, pp. 283-291
-
-
Okanoue, T.1
Sakamoto, S.2
Itoh, Y.3
-
5
-
-
0036830454
-
Side effects of therapy of hepatitis C and their management
-
Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 36: S237-244, 2002.
-
(2002)
Hepatology
, vol.36
-
-
Fried, M.W.1
-
6
-
-
33644804915
-
Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
-
Iwasaki Y, Ikeda H, Arald Y, et al. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C. Hepatology 43: 54-63, 2006.
-
(2006)
Hepatology
, vol.43
, pp. 54-63
-
-
Iwasaki, Y.1
Ikeda, H.2
Arald, Y.3
-
7
-
-
0032801727
-
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis
-
Schalm SW, Weiland O, Hansen BE, et al. Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis. Gastroenterology 117: 408-413, 1999.
-
(1999)
Gastroenterology
, vol.117
, pp. 408-413
-
-
Schalm, S.W.1
Weiland, O.2
Hansen, B.E.3
-
8
-
-
0036788338
-
International Hepatitis Interventional Therapy Group. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
-
McHutchison JG, Manns M, Patel K, et al. International Hepatitis Interventional Therapy Group. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 123: 1061-1069, 2002.
-
(2002)
Gastroenterology
, vol.123
, pp. 1061-1069
-
-
McHutchison, J.G.1
Manns, M.2
Patel, K.3
-
9
-
-
11144358311
-
Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment
-
Shiffinan ML, Di Bisceglie AM, Lindsay KL, et al. Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology 126: 1015-1023, 2004.
-
(2004)
Gastroenterology
, vol.126
, pp. 1015-1023
-
-
Shiffinan, M.L.1
Di Bisceglie, A.M.2
Lindsay, K.L.3
-
10
-
-
33846356749
-
Impact of reducing peginterferon alfa-2a and ribavirin dose during refreatment in patients with chronic hepatitis C
-
Shiffman ML, Ghany MG, Morgan TR, et al. Impact of reducing peginterferon alfa-2a and ribavirin dose during refreatment in patients with chronic hepatitis C. Gastroenterology 132: 103-112, 2007.
-
(2007)
Gastroenterology
, vol.132
, pp. 103-112
-
-
Shiffman, M.L.1
Ghany, M.G.2
Morgan, T.R.3
-
11
-
-
0031918127
-
Multicenter evaluation of the Cobas Amplicor HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory
-
Albadalejo J, Alonso R, Antinozzi R, et al. Multicenter evaluation of the Cobas Amplicor HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory. J Clin Microbiol 36: 862-865, 1998.
-
(1998)
J Clin Microbiol
, vol.36
, pp. 862-865
-
-
Albadalejo, J.1
Alonso, R.2
Antinozzi, R.3
-
12
-
-
0032947751
-
Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant
-
Doglio A, Laffont C, Caroli-Bose FX, et al. Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant. J Chn Microbiól 37: 1567-1569, 1999.
-
(1999)
J Chn Microbiól
, vol.37
, pp. 1567-1569
-
-
Doglio, A.1
Laffont, C.2
Caroli-Bose, F.X.3
-
13
-
-
84989559703
-
Hepatitis C virus genotypes; an investigation of type-specific differences in geographic origin and disease
-
Dusheiko G, Schmilovitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes; an investigation of type-specific differences in geographic origin and disease. Hepatology 19: 13-18, 1994.
-
(1994)
Hepatology
, vol.19
, pp. 13-18
-
-
Dusheiko, G.1
Schmilovitz-Weiss, H.2
Brown, D.3
-
14
-
-
0028235641
-
Classification of chronic hepatitis: Diagnosis, grading and staging
-
Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520, 1994.
-
(1994)
Hepatology
, vol.19
, pp. 1513-1520
-
-
Desmet, V.J.1
Gerber, M.2
Hoofnagle, J.H.3
-
15
-
-
0041822106
-
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
-
Davis GL, Wong JB, McHutchison JG, et al. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 38: 645-652, 2003.
-
(2003)
Hepatology
, vol.38
, pp. 645-652
-
-
Davis, G.L.1
Wong, J.B.2
McHutchison, J.G.3
-
16
-
-
33749360440
-
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin
-
Bronowicki JP, Ouzan D, Asselah T, et al. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin. Gastroenterology 131: 1040-1048, 2006.
-
(2006)
Gastroenterology
, vol.131
, pp. 1040-1048
-
-
Bronowicki, J.P.1
Ouzan, D.2
Asselah, T.3
-
17
-
-
33744796300
-
A study of low dose peginterferon alpha-2b with ribavirin for the initial treatment of chronic hepatitis C
-
for the New York New England Study Team
-
Krawitt EL, Gordon SR, Grace ND, et al. for the New York New England Study Team. A study of low dose peginterferon alpha-2b with ribavirin for the initial treatment of chronic hepatitis C. Am J Gastroenterol 101: 1268-1273, 2006.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 1268-1273
-
-
Krawitt, E.L.1
Gordon, S.R.2
Grace, N.D.3
|